Belpointe Asset Management’s Galectin Therapeutics GALT Stock Holding History

Belpointe Asset Management’s Portfolio GALT Stock Details GALT Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$442K	Buy
2023 Q2	–	Sell
2023 Q1	$2.24K	Hold
2022 Q4	$1.21K	Buy
2019 Q3	–	Sell
2019 Q2	$121K	Buy
2019 Q1	$138K	Buy
2018 Q4	–	Sell
2018 Q3	$187K	Sell
2018 Q2	$277K	Buy